`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Addl'fiss. COMMISSIONER FOR PATENTS
`PO Box 1450
`Alexandria, Vfigmia 22313-1450
`wwwuspto.gov
`
`APPLICATION
`NUMBER
`
`FILING or
`371(0) DATE
`
`GRP ART
`UNIT
`
`
`
`
`
`F
`
`15/707,908
`
`09/18/2017
`
`FEE REC'D
`
`0.00
`
`23581
`
`5&LLSACCHIFTSELYIBLNLJ'C'
`
`520 SW YAMHILL STREET
`
`PORTLAND, OR 97204
`
`ATTY.DOCKET.NO
`
`QLI3A05
`
`TOT CLAHVIS IND CLAIMS
`40
`6
`
`CONFIRMATION NO. 5593
`
`FILING RECEIPT
`
`lllllllllllllllllllllllllUlllWllllllllllllllllllllllllllllllllllllllll
`
`Date Mailed: 10/13/2017
`
`Receipt is acknowledged of this non-provisional patent application. The application will be taken up for examination
`in due course. Applicant will be notified as to the results of the examination. Any correspondence concerning the
`application must include the following identification information: the US. APPLICATION NUMBER, FILING DATE,
`NAME OF APPLICANT, and TITLE OF INVENTION. Fees transmitted by check or draft are subject to collection.
`Please verify the accuracy of the data presented on this receipt. If an error is noted on this Filing Receipt, please
`submit a written request for a Filing Receipt Correction. Please provide a copy of this Filing Receipt with the
`changes noted thereon. If you received a "Notice to File Missing Parts" for this application, please submit
`any corrections to this Filing Receipt with your reply to the Notice. When the USPTO processes the reply
`to the Notice, the USPTO will generate another Filing Receipt incorporating the requested corrections
`
`lnventor(s)
`
`Applicant(s)
`
`Amy L. Hiddessen, Tracy, CA;
`Donald A. Masquelier, Tracy, CA;
`Kevin D. Ness, Pleasanton, CA;
`Benjamin J. Hindson, Livermore, CA;
`Anthony J. Makarewicz Jr., Livermore, CA;
`Erin R. Chia, Walnut Creek, CA;
`Billy W. Colston Jr., San Ramon, CA;
`Serge Saxonov, Oakland, CA;
`Svilen S. Tzonev, Pleasanton, CA;
`Michael Y. Lucero, San Francisco, CA;
`Ryan T. Koehler, West Linn, OR;
`
`Bio-Rad Laboratories, Inc, Hercules, CA;
`
`Power of Attorney: None
`
`Domestic Priority data as claimed by applicant
`This application is a CON of 15/351 ,354 11/14/2016 PAT 9764322
`which is a CIP of 12/954,634 11/25/2010 ABN
`and is a CIP of 13/400,030 02/17/2012 ABN
`and is a CIP of 14/020,742 09/06/2013
`and is a CIP of 14/159,410 01/20/2014 PAT 9492797
`and is a CIP of 14/201,752 03/07/2014
`and is a CIP of 14/848,311 09/08/2015
`and said 14/159,410 01/20/2014
`is a CIP of 12/586,626 09/23/2009 PAT 9156010
`page 1 of 6
`
`

`

`and is a C|P of 12/862,542 08/24/2010 PAT 9194861
`and is a C|P of 12/890,550 09/24/2010 PAT 8633015
`and is a C|P of 13/245,575 09/26/2011 ABN
`and is a C|P of 13/945,661 07/18/2013 PAT 9417190
`and is a C|P of 12/962,507 12/07/2010 PAT 9216392
`and is a C|P of 12/962,511 12/07/2010 PAT 9623384
`and is a C|P of 12/962,502 12/07/2010 PAT 9248417
`and is a C|P of 12/963,523 12/08/2010 PAT 9126160
`and is a C|P of 13/039,233 03/02/201 1 PAT 8709762
`and is a C|P of 12/976,827 12/22/2010 PAT 9598725
`and is a C|P of 13/341,669 12/30/2011 PAT 9500664
`and is a C|P of 13/341,678 12/30/2011 PAT 8730479
`and is a C|P of 13/072,673 03/25/2011 PAT 9132394
`and is a C|P of 13/341,688 12/30/2011 PAT 9393560
`and is a C|P of 13/287,120 11/01/2011 PAT 9089844
`and is a C|P of 13/424,304 03/19/2012 PAT 9222128
`and is a C|P of 13/548,062 07/12/2012 PAT 8951939
`and is a C|P of PCT/US2012/048198 07/25/2012
`
`and is a C|P of 13/562,198 07/30/2012 PAT 8663920
`and is a C|P 0f13/287,095 11/01/2011 ABN
`and is a C|P of 13/863,231 04/15/2013 PAT 9399215
`and said 12/586,626 09/23/2009
`Claims benefit of 61/194,043 09/23/2008
`and Claims benefit of 61/206,975 02/05/2009
`and Claims benefit of 61/271,538 07/21/2009
`and Claims benefit of 61/275,731 09/01/2009
`and Claims benefit of 61/277,200 09/21/2009
`and Claims benefit of 61/277,203 09/21/2009
`and Claims benefit of 61/277,204 09/21/2009
`and Claims benefit of 61/277,216 09/21/2009
`and Claims benefit of 61/277,249 09/21/2009
`and Claims benefit of 61/277,270 09/22/2009
`and said 12/862,542 08/24/2010
`Claims benefit of 61/275,860 09/02/2009
`and said 12/890,550 09/24/2010
`is a C|P of 12/586,626 09/23/2009 PAT 9156010
`and said 13/245,575 09/26/2011
`is a CON of 12/586,626 09/23/2009 PAT 9156010
`and said 13/945,661 07/18/2013
`is a C|P 0f13/251,016 09/30/2011 ABN
`and is a C|P of 13/245,575 09/26/2011 ABN
`and is a C|P of 12/976,827 12/22/2010 PAT 9598725
`and said 12/962,507 12/07/2010
`is a CON of 12/586,626 09/23/2009 PAT 9156010
`and said 12/962,511 12/07/2010
`is a CON of 12/586,626 09/23/2009 PAT 9156010
`and said 12/962,502 12/07/2010
`is a CON of 12/586,626 09/23/2009 PAT 9156010
`and said 12/963,523 12/08/2010
`is a CON of 12/586,626 09/23/2009 PAT 9156010
`and said 13/039,233 03/02/2011
`
`page 2 of 6
`
`

`

`claims benefit of 61/309,837 03/02/2010
`and said 12/976,827 12/22/2010
`claims benefit of 61/309,845 03/02/2010
`and claims benefit of 61/341,218 03/25/2010
`and claims benefit of 61/317,635 03/25/2010
`and claims benefit of 61/380,981 09/08/2010
`and claims benefit of 61/409,106 11/01/2010
`and claims benefit of 61/409,473 11/02/2010
`and claims benefit of 61/410,769 11/05/2010
`and claims benefit of 61/417,241 11/25/2010
`and said 13/341 ,669 12/30/2011
`is a CON of PCT/US2011/030101 03/25/2011
`
`which claims benefit of 61/341,218 03/25/2010
`and said 13/341,678 12/30/2011
`is a CON of PCT/US2011/030077 03/25/2011
`
`which claims benefit of 61/317,684 03/25/2010
`and said 13/072,673 03/25/2011
`claims benefit of 61/317,635 03/25/2010
`and claims benefit of 61/467,347 03/24/2011
`and is a CIP of 12/586,626 09/23/2009 PAT 9156010
`and said 13/341,688 12/30/2011
`is a CON of PCT/US2011/030097 03/25/2011
`
`which claims benefit of 61/341,065 03/25/2010
`and claims benefit of 61/467,347 03/24/2011
`and said 13/287,120 11/01/2011
`claims benefit of 61/409,106 11/01/2010
`and claims benefit of 61/409,473 11/02/2010
`and claims benefit of 61/410,769 11/05/2010
`and said 13/424,304 03/19/2012
`claims benefit of 61/454,373 03/18/2011
`and said 13/548,062 07/12/2012
`claims benefit of 61/507,082 07/12/2011
`and claims benefit of 61/510,013 07/20/2011
`and said PCT/US2012/048198 07/25/2012
`
`claims benefit of 61/511,445 07/25/2011
`and said 13/562,198 07/30/2012
`claims benefit of 61/513,474 07/29/2011
`and claims benefit of 61/601,514 02/21/2012
`and said 13/287,095 11/01/2011
`is a CIP of 12/976,827 12/22/2010 PAT 9598725
`and said 13/863,231 04/15/2013
`claims benefit of 61/624,199 04/13/2012
`and said 12/954,634 11/25/2010
`claims benefit of 61/264,591 11/25/2009
`and claims benefit of 61/309,845 03/02/2010
`and claims benefit of 61/309,837 03/02/2010
`and claims benefit of 61/317,684 03/25/2010
`and claims benefit of 61/317,635 03/25/2010
`and claims benefit of 61/317,639 03/25/2010
`and claims benefit of 61/341,065 03/25/2010
`and claims benefit of 61/341,218 03/25/2010
`page 3 of 6
`
`

`

`and claims benefit of 61/380,981 09/08/2010
`and claims benefit of 61/409,106 11/01/2010
`and claims benefit of 61/409,473 11/02/2010
`and claims benefit of 61/410,769 11/05/2010
`and said 13/400,030 02/17/2012
`claims benefit of 61/444,674 02/18/2011
`and claims benefit of 61/449,580 03/04/2011
`and claims benefit of 61/453,537 03/16/2011
`and claims benefit of 61/478,777 04/25/2011
`and claims benefit of 61/488,667 05/20/2011
`and claims benefit of 61/490,040 05/25/2011
`and said 14/020,742 09/06/2013
`claims benefit of 61/697,982 09/07/2012
`and said 14/201,752 03/07/2014
`claims benefit of 61/775,415 03/08/2013
`and said 14/848,311 09/08/2015
`is a DIV of 13/385,277 02/09/2012 PAT 9127312
`which claims benefit of 61/441,209 02/09/2011
`and claims benefit of 61/444,539 02/18/2011
`and claims benefit of 61/454,373 03/18/2011
`and claims benefit of 61/476,1 15 04/15/2011
`and claims benefit of 61/478,777 04/25/2011
`and claims benefit of 61/484,197 05/09/2011
`and claims benefit of 61/490,055 05/25/2011
`
`Foreign Applications for which priority is claimed (You may be eligible to benefit from the Patent Prosecution
`Highway program at the USPTO. Please see http://www.uspto.gov for more information.) - None.
`Foreign application information must be provided in an Application Data Sheet in order to constitute a claim to
`foreign priority. See 37 CFR 1.55 and 1.76.
`
`Permission to Access Application via Priority Document Exchange: Yes
`
`Permission to Access Search Results: Yes
`
`Applicant may provide or rescind an authorization for access using Form PTO/SB/39 or Form PTO/SB/69 as
`appropriate.
`
`If Required, Foreign Filing License Granted: 10/12/2017
`
`The country code and number of your priority application, to be used for filing abroad under the Paris Convention,
`is US 15/707,908
`
`Projected Publication Date: To Be Determined - pending completion of Missing Parts
`
`Non-Publication Request: No
`
`Early Publication Request: No
`Title
`
`DROPLET-BASED ANALYSIS METHOD
`
`Preliminary Class
`
`Statement under 37 CFR 1.55 or 1.78 for AIA (First Inventor to File) Transition Applications: No
`page 4 of 6
`
`

`

`PROTECTING YOUR INVENTION OUTSIDE THE UNITED STATES
`
`Since the rights granted by a US. patent extend only throughout the territory of the United States and have no
`effect in a foreign country, an inventor who wishes patent protection in another country must apply for a patent
`in a specific country or in regional patent offices. Applicants may wish to consider the filing of an international
`application under the Patent Cooperation Treaty (PCT). An international (PCT) application generally has the same
`effect as a regular national patent application in each PCT-member country. The PCT process simplifies the filing
`of patent applications on the same invention in member countries, but does not result in a grant of "an international
`patent" and does not eliminate the need of applicants to file additional documents and fees in countries where patent
`protection is desired.
`
`Almost every country has its own patent law, and a person desiring a patent in a particular country must make an
`application for patent in that country in accordance with its particular laws. Since the laws of many countries differ
`in various respects from the patent law of the United States, applicants are advised to seek guidance from specific
`foreign countries to ensure that patent rights are not lost prematurely.
`
`Applicants also are advised that in the case of inventions made in the United States, the Director of the USPTO must
`issue a license before applicants can apply for a patent in a foreign country. The filing of a US. patent application
`serves as a request for a foreign filing license. The application's filing receipt contains further information and
`guidance as to the status of applicant's license for foreign filing.
`
`Applicants may wish to consult the USPTO booklet, "General Information Concerning Patents" (specifically, the
`section entitled "Treaties and Foreign Patents") for more information on timeframes and deadlines for filing foreign
`patent applications. The guide is available either by contacting the USPTO Contact Center at 800-786-9199, or it
`can be viewed on the USPTO website at http://www.uspto.gov/web/offices/pac/doc/general/index.html.
`
`For information on preventing theft of your intellectual property (patents, trademarks and copyrights), you may wish
`to consult the US. Government website, http://www.stopfakes.gov. Part of a Department of Commerce initiative,
`this website includes self-help "toolkits" giving innovators guidance on how to protect intellectual property in specific
`countries such as China, Korea and Mexico. For questions regarding patent enforcement issues, applicants may
`call the US. Government hotline at 1-866-999-HALT (1-866-999-4258).
`
`LICENSE FOR FOREIGN FILING UNDER
`
`Title 35, United States Code, Section 184
`
`Title 37, Code of Federal Regulations, 5.11 & 5.15
`
`GRANTED
`
`if the phrase "IF REQUIRED, FOREIGN FILING
`The applicant has been granted a license under 35 U.S.C. 184,
`LICENSE GRANTED" followed by a date appears on this form. Such licenses are issued in all applications where
`the conditions for issuance of a license have been met, regardless of whether or not a license may be required as
`set forth in 37 CFR 5.15. The scope and limitations of this license are set forth in 37 CFR 5.15(a) unless an earlier
`license has been issued under 37 CFR 5.15(b). The license is subject to revocation upon written notification. The
`date indicated is the effective date of the license, unless an earlier license of similar scope has been granted under
`37 CFR 5.13 or 5.14.
`
`page 5 of 6
`
`